Ancient wheats: beneficial effects on insulin resistance.


Journal

Minerva medica
ISSN: 1827-1669
Titre abrégé: Minerva Med
Pays: Italy
ID NLM: 0400732

Informations de publication

Date de publication:
Oct 2021
Historique:
pubmed: 31 7 2020
medline: 15 12 2021
entrez: 31 7 2020
Statut: ppublish

Résumé

Non-alcoholic fatty liver disease and type 2 diabetes mellitus are two conditions that commonly co-exist in the context of metabolic syndrome. Several scientific advances in understanding this association have identified insulin resistance as the key point in the pathogenesis of both diseases. The first line treatment suggested in the management of these diseases is represented by lifestyle changes, and in particular, the modification of alimentary regimen, with the transition to a healthy diet. In this context, several studies have focused their attention on the identification of food products with beneficial actions, like ancient wheat (AW). AW is defined as the early cereals that were domesticated in their places of origin in the "Fertile Crescent" of the Middle East, and played a central role as a main source of food for the early civilizations in that region. The present narrative review aims at providing a systematic overview of the state of the art on the effects of AW on insulin resistance.

Identifiants

pubmed: 32729704
pii: S0026-4806.20.06873-1
doi: 10.23736/S0026-4806.20.06873-1
doi:

Substances chimiques

Anti-Inflammatory Agents 0
Antioxidants 0

Types de publication

Journal Article Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

641-650

Auteurs

Ludovico Abenavoli (L)

Department of Health Sciences, University Magna Graecia, Catanzaro, Italy - l.abenavoli@unicz.it.

Maja Milanovic (M)

Faculty of Medicine, Department of Pharmacy, University of Novi Sad, Novi Sad, Serbia.

Anna C Procopio (AC)

Department of Health Sciences, University Magna Graecia, Catanzaro, Italy.

Giovanni Spampinato (G)

Department of Agriculture, University Mediterranea, Reggio Calabria, Italy.

Gina Maruca (G)

Institute of Biosciences and Bioresources, National Research Council, Bari, Italy.

Enrico V Perrino (EV)

CIHEAM, Mediterranean Agronomic Institute, Valenzano, Bari, Italy.

Gaia C Mannino (GC)

Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.

Sharmila Fagoonee (S)

Institute of Biostructure and Bioimaging, National Research Council c/o Molecular Biotechnology Center, Turin, Italy.

Francesco Luzza (F)

Department of Health Sciences, University Magna Graecia, Catanzaro, Italy.

Carmelo M Musarella (CM)

Department of Agriculture, University Mediterranea, Reggio Calabria, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH